Literature DB >> 2387685

Hypoxic effects on corneal morphology and function.

K A Polse1, R J Brand, S R Cohen, M Guillon.   

Abstract

Normal corneal metabolism depends on a critical level of oxygen, below which a series of acute corneal responses occur, including an increase in stromal lactate, a reduction in intercellular pH, and an increase in corneal hydration. These acute responses are reversible when normal oxygen is restored; however, it has been shown that chronic exposure to low oxygen levels can result in permanent morphologic changes in the corneal endothelium. Clinicians have expressed concern that these observed structural changes may also be accompanied by alterations in corneal physiology. Whether such effects occur is not known, since it has been difficult to assess human corneal function accurately. Recently, we have developed an in vivo test, able to measure overall corneal hydration control, that can be used to study the effects of hypoxia on corneal function. This test provides information on several characteristics of hydration control, one of which is the percent corneal thickness recovery per hour (PRPH) after inducing corneal swelling. In this study, we assumed that corneal hypoxia accompanies both extended and polymethylmethacrylate (PMMA) contact lens wear and that the dose received is related to the years of past lens wear. Using this paradigm, we explored the relationship of hypoxic dose to an endothelial polymegethism index (EPI), endothelial cell density (ECD), and PRPH in 36 subjects with varying contact lens wearing histories. Based on multiple regression analysis, the relative change (expressed as percent per year) associated with hypoxic dose (adjusted for age and gender) was found to be dose-dependent and corresponded to estimated changes of 1.70%/yr, -0.25%/yr, and -1.26%/yr, with 95% confidence limits of (-0.3, 3.7), (-1.4, 0.9), and (-2.6, 0.06) for EPI, ECD, and PRPH, respectively. These preliminary data suggest that hypoxic exposure alters endothelial morphology and reduces corneal function; however, it is important to indicate that this was a exploratory investigation with several limitations, and that therefore these results should be viewed as preliminary until more definitive studies are completed.

Entities:  

Mesh:

Year:  1990        PMID: 2387685

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

Review 1.  Disease and risks associated with contact lenses.

Authors:  J K Dart
Journal:  Br J Ophthalmol       Date:  1993-01       Impact factor: 4.638

Review 2.  Corneal endothelium: developmental strategies for regeneration.

Authors:  J Zavala; G R López Jaime; C A Rodríguez Barrientos; J Valdez-Garcia
Journal:  Eye (Lond)       Date:  2013-03-08       Impact factor: 3.775

Review 3.  Purinergic Signaling in Corneal Wound Healing: A Tale of 2 Receptors.

Authors:  Martin S Minns; Vickery Trinkaus-Randall
Journal:  J Ocul Pharmacol Ther       Date:  2016-09-19       Impact factor: 2.671

4.  Effect of Stem Cell-Derived Extracellular Vesicles on Damaged Human Corneal Endothelial Cells.

Authors:  Raffaele Nuzzi; Lola Buono; Simona Scalabrin; Marco De Iuliis; Benedetta Bussolati
Journal:  Stem Cells Int       Date:  2021-01-16       Impact factor: 5.443

5.  Extracellular Vesicles Derived From Human Corneal Endothelial Cells Inhibit Proliferation of Human Corneal Endothelial Cells.

Authors:  Mohit Parekh; Hefin Rhys; Tiago Ramos; Stefano Ferrari; Sajjad Ahmad
Journal:  Front Med (Lausanne)       Date:  2022-02-04

6.  Influence of Contact Lens Materials and Cleaning Procedures on Bacterial Adhesion and Biofilm Formation.

Authors:  Auemphon Mordmuang; Lunla Udomwech; Kulwadee Karnjana
Journal:  Clin Ophthalmol       Date:  2021-06-08

Review 7.  Targeting Ocular Drug Delivery: An Examination of Local Anatomy and Current Approaches.

Authors:  Emily Dosmar; Julia Walsh; Michael Doyel; Katlynn Bussett; Adekite Oladipupo; Sabri Amer; Katherine Goebel
Journal:  Bioengineering (Basel)       Date:  2022-01-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.